Levetiracetam is named as a drug or biological intervention in 6 clinical trials in our China, India and USA trial registers, 4 of which are recruiting. Lead sponsors include Myrtelle Inc. (1), All India Institute of Medical Sciences, Jodhpur (1) and Tata Memorial Centre (1). Registered phases: Phase 3, Phase 1/2, Phase 4 and Phase 2. Conditions studied include Seizures; Canavan Disease; Traumatic Brain Injuries.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Seizures | 2 |
| Canavan Disease | 1 |
| Traumatic Brain Injuries | 1 |
| Traumatic Brain Injury (TBI) Patients | 1 |
| Brain Tumors | 1 |
| Antiepileptics | 1 |
| Levetiracetam | 1 |
| Suspected Stroke | 1 |
| Postoperative Seizures After Brain Tumor Surgery | 1 |
| Glioblastoma | 1 |
| Lead sponsor | Trials |
|---|---|
| Myrtelle Inc. | 1 |
| All India Institute of Medical Sciences, Jodhpur | 1 |
| Tata Memorial Centre | 1 |
| Shanghai East Hospital | 1 |
| Beijing Tiantan Hospital | 1 |
| Tianjin Medical University General Hospital | 1 |
| Register | Levetiracetam trials |
|---|---|
| Clinical trials in China | 3 |
| Clinical trials in India | 2 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Levetiracetam works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Levetiracetam (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.